Cargando…
Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells
Hyperhomocysteinemia (HHcy) is an established and potent independent risk factor for degenerative diseases, including cardiovascular disease (CVD), Alzheimer disease, type II diabetes mellitus, and chronic kidney disease. HHcy has been shown to inhibit proliferation and promote inflammatory response...
Autores principales: | Jan, Michael, Cueto, Ramon, Jiang, Xiaohua, Lu, Liu, Sardy, Jason, Xiong, Xinyu, Yu, Justine E., Pham, Hung, Khan, Mohsin, Qin, Xuebing, Ji, Yong, Yang, Xiao-Feng, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282538/ https://www.ncbi.nlm.nih.gov/pubmed/34140262 http://dx.doi.org/10.1016/j.redox.2021.102018 |
Ejemplares similares
-
Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease
por: Wang, Xianwei, et al.
Publicado: (2023) -
Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
por: Dubchenko, Ekaterina, et al.
Publicado: (2020) -
Nitrative Stress Participates in Endothelial Progenitor Cell Injury in Hyperhomocysteinemia
por: Dong, Yu, et al.
Publicado: (2016) -
Hyperhomocysteinemia: Focus on Endothelial Damage as a Cause of Erectile Dysfunction
por: Salvio, Gianmaria, et al.
Publicado: (2021) -
Cardiomyocyte Ploidy, Metabolic Reprogramming and Heart Repair
por: Elia, Andrea, et al.
Publicado: (2023)